Description

Retatrutide 20mg + Tirzepatide 40mg | Elite Dual GLP Research Blend 60mg | Laboratory Research Compound | Mile High Peptides LLC

Commonly Researched For:

• Advanced GLP-style metabolic signaling

• Appetite, satiety, and body-weight models

• Blood-sugar control and energy-balance research

Description

This advanced blend combines Retatrutide (a multi-receptor GLP-related compound) with Tirzepatide (a dual GIP/GLP-1 agonist) into a single high-load 60mg vial. It is designed for labs running sophisticated metabolic studies that want to explore overlapping and complementary incretin pathways in the same experimental setup.

Researchers commonly explore this combination in in‑vitro models that track appetite signals, caloric intake patterns, insulin and glucose-related markers, and weight-associated endpoints. By working with both Retatrutide and Tirzepatide together, they can design experiments that probe how multiple incretin-style signals might interact to influence energy balance and metabolic control.

Mile High Peptides LLC supplies this compound for research and educational purposes.

Product Details

• Total compound: 60mg
• Lyophilized powder format
• Laboratory research use only
• Intended for analytical and in-vitro research applications

Important Notice

• For laboratory research and educational purposes only
• Not for human consumption
• Not for medical, cosmetic, or therapeutic use
• Not intended to diagnose, treat, cure, or prevent any disease
• Observations and research outcomes may vary based on handling, storage, environment, methodology, and study conditions
• Materials supplied are not finished consumer products

Mile High Peptides LLC supplies materials strictly for in-vitro laboratory research and analytical applications by qualified research professionals.